Information for Clinicians on Investigational Therapeutics for Patients with COVID-19

Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 4/25/2020. This web page, updated on April 25, 2020, discusses how there are no Food and Drug Administration (FDA)-approved drugs specifically for the treatment of patients with COVID-19. At present, clinical management includes infection prevention and control measures and supportive care, including supplementary oxygen and mechanical ventilatory support when indicated. It provides links to National Institutes of Health guidance and information about clinical trials. (Text)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - Category: International Medicine & Public Health Source Type: news